Medical Equipment

Circulating Tumor Cells Market Analysis Reflecting Expansion Trends And Industry Performance

May 12, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Circulating Tumor Cells Market During The Forecast Period?

The circulating tumor cells market size has seen swift expansion in recent years. It is projected to grow from $13.27 billion in 2025 to $14.99 billion in 2026, with a compound annual growth rate (CAGR) of 13.0%. The growth observed in previous periods can be attributed to factors such as increasing cancer incidence rates, the expansion of oncology research programs, the growing application of blood-based diagnostics, a rising adoption of minimally invasive testing methods, and the availability of advanced laboratory technologies.

The market size for circulating tumor cells is projected to experience swift expansion over the coming years, anticipated to reach $23.88 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. The expansion anticipated during the forecast period is fueled by factors such as the greater acceptance of personalized oncology diagnostics, increased funding in cancer biomarker research, the proliferation of automated cell capture technologies, a rising need for tools capable of early-stage cancer detection, and the growing incorporation of AI in oncology diagnostics. Key trends identified for this period encompass the increased application of liquid biopsy techniques, a growing uptake of microfluidic CTC isolation devices, the broader integration of automated CTC analysis systems, an expansion in oncology research applications, and a heightened emphasis on the early detection of cancer.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

Which Core Factors Are Supporting The Expansion Of The Circulating Tumor Cells Market?

The increasing incidence of cancer is anticipated to propel the circulating tumor cells market growth in the coming period. Cancer is defined as a condition where certain body cells multiply uncontrollably and spread to other areas of the body. Circulating tumor cells play a role in the early detection and diagnosis of cancer, thus the rising occurrence of cancer drives the expansion of the circulating tumor cells market. For instance, in February 2024, the World Health Organization, a Switzerland-based international organization dedicated to global health policy and public health initiatives, predicted over 35 million new cancer cases by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Consequently, the growing incidence of cancer is fueling the growth of the circulating tumor cells market.

How Are Different Segment Groups Identified Within The Circulating Tumor Cells Market?

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

Which Trends Are Guiding The Development Of The Circulating Tumor Cells Market?

Major companies within the circulating tumor cells (CTC) market are concentrating on creating innovative solutions, such as biomarker-specific CTC assays, to address the growing need for precise, non-invasive cancer diagnostics and advanced personalized therapy monitoring. Biomarker-specific CTC assays facilitate the identification and profiling of circulating tumor cells based on particular protein expression, offering more detailed phenotypic information compared to traditional CTC enumeration methods, which primarily provide total cell counts without distinguishing biomarkers. For instance, in July 2023, Menarini Silicon Biosystems S.p.A., an Italy-based diagnostics company, launched the CELLSEARCH CTC test featuring the DLL3 biomarker, now accessible as a Research Use Only (RUO) service in North America and Europe. This assay utilizes the FDA-cleared CELLSEARCH platform to detect circulating tumor cells expressing DLL3, a protein highly expressed in aggressive small-cell lung cancer (SCLC) and neuroendocrine tumors. By focusing on DLL3, the test allows for phenotypic characterization of CTCs associated with poor prognosis, assisting biopharma research in developing targeted therapies. This advancement provides researchers with a non-invasive instrument to investigate tumor heterogeneity, track disease progression, and assess the effectiveness of targeted treatments.

Who Are The Companies Shaping The Circulating Tumor Cells Market Landscape?

Major companies operating in the circulating tumor cells market are BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., ScreenCell SAS, Aviva Biosciences Corporation, LungLife AI Inc., Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd., Bio-Techne Corporation, Qiagen N.V., STEMCELL Technologies Inc., Sysmex Corporation, Miltenyi Biotec GmbH, Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Agilent Technologies Inc.

Access The Complete Circulating Tumor Cells Market Report:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Which Regional Market Leads The Circulating Tumor Cells Market?

North America was the largest region in the circulating tumor cells market in 2025. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Circulating Tumor Cells Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

Browse Through More Reports Similar to the Global Circulating Tumor Cells Market 2026, By The Business Research Company

Chronic Obstructive Pulmonary Disease Copd Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-treatment-global-market-report

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795